Search
Support us

Oncode Institute

The Dutch collaboration to outsmart cancer and impact lives

Oncode Institute is a Dutch cancer research and innovation organisation dedicated to accelerating breakthroughs in cancer research and translating them into impactful diagnostics and treatments. More than 750 cancer researchers from 13 academic centers in the Netherlands collaborate in groundbreaking fundamental research. Through an integrated approach that bridges discovery, clinical practice, and market needs, Oncode Institute drives the transformation of innovations into tangible benefits for patients. 

The Netherlands Cancer Institute currently hosts 17 Oncode research groups.

The added value of Oncode

Rene Bernards was one of the initiators of Oncode. Here, he expands on the added value of Oncode in translating true scientific innovations into true clinical innovations.

Laura Bornes

Insights from Researcher Laura Bornes

Could timing chemo with the menstrual cycle improve breast cancer treatment? That’s the bold question researcher Laura Bornes was addressing during her PhD. She is awarded with recognition from the BOOG Young Investigator Award. She performed her PhD in the lab of Oncode Investigator Jacco van Rheenen’s lab, taking part in Oncode Institute’s Patient Perspective Program. Based on her work, and with support by Oncode Insitute, a pioneering clinical study is launched that could lead to a simple yet powerful change in how we treat triple-negative breast cancer. 

Read the interview

Learn more about our…

Organisation

Visit the Oncode website

Oncode institute

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.